The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice.

Autor: Walter, Johannes¹ (AUTHOR) jannisme@icloud.com, Mende, Jannis¹ (AUTHOR) hutagalung.dra@gmail.com, Hutagalung, Samuel¹ (AUTHOR) obada.alhalabi@med.uni-heidelberg.de, Alhalabi, Obada T.¹ (AUTHOR) martin.grutza@med.uni-heidelberg.de, Grutza, Martin¹ (AUTHOR) g.zheng@stud.uni-heidelberg.de, Zheng, Guoli¹ (AUTHOR) andreas.unterberg@med.uni-heidelberg.de, Skutella, Thomas² (AUTHOR) skutella@ana.uni-heidelberg.de, Unterberg, Andreas¹ (AUTHOR) k.zweckberger@klinikum-braunschweig.de, Zweckberger, Klaus¹ (AUTHOR), Younsi, Alexander¹ (AUTHOR) johannes.walter@med.uni-heidelberg.de

Publikováno v: International Journal of Molecular Sciences. Aug2023, Vol. 24 Issue 16, p12756. 17p.

Die Applikation von Interleukin-4 reduziert den sekundären Hirnschaden nach experimentellem Schädel-Hirn-Trauma im Mausmodell

Autor: Walter, Johannes, Hutagalung, Samuel, Mende, Jannis, Maurer, Christa, Kirsch, Joachim, Skutella, Thomas, Younsi, Alexander, Unterberg, Andreas W., Zweckberger, Klaus

Publikováno v: 72. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgie; 20210606-20210609; sine loco [digital]; DOCV031 /20210604/

Objective: Recent focus of experimental research in traumatic brain injury (TBI) has been directed towards the role of inflammatory processes. It has been shown that activation of the Interleukin-4 (IL-4) pathway ameliorates secondary brain injury; t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b30aeeb684723a08710fab330959e47
http://nbn-resolving.de/urn:nbn:de:0183-21dgnc0332